Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016

Abstract

This cohort study used the Drugs@FDA database to identify new drugs approved by the US Food and Drug Administration (FDA) and assess fulfillment of postmarket commitments and requirements.